Fujian Haixi Pharmaceuticals Files for Hong Kong IPO
CompanyDeals

Fujian Haixi Pharmaceuticals Files for Hong Kong IPO

SciClone and Menarini Submit NDA for Vaborem in China
CompanyDrug

SciClone and Menarini Submit NDA for Vaborem in China

Servier and Google Cloud Extend Partnership to Advance AI in Drug Development
CompanyDeals

Servier and Google Cloud Extend Partnership to Advance AI in Drug Development

Cathay Biotech Plans $901M Private Placement to Boost Bio-Based Materials
CompanyDeals

Cathay Biotech Plans $901M Private Placement to Boost Bio-Based Materials

Simcere Licenses Fermion's AI-Enabled Painkiller FZ002-037
CompanyDeals

Simcere Licenses Fermion’s AI-Enabled Painkiller FZ002-037

Boston Scientific's FARAPULSE and WATCHMAN FLX Studies Show Positive Results
CompanyMedical Device

Boston Scientific’s FARAPULSE and WATCHMAN FLX Studies Show Positive Results

Asieris' USP1 Inhibitor APL-2302 Cleared for Clinical Trials
CompanyDrug

Asieris’ USP1 Inhibitor APL-2302 Cleared for Clinical Trials

Zhejiang Huahai's HB0056 Approved for US Phase I Asthma Trial
CompanyDrug

Zhejiang Huahai’s HB0056 Approved for US Phase I Asthma Trial

Hengrui's HER2-Targeted ADC and Antibody Drug Combo Approved for Trials
CompanyDrug

Hengrui’s HER2-Targeted ADC and Antibody Drug Combo Approved for Trials

CSPC's SYS 6043 Receives FDA Approval for Clinical Trials
CompanyDrug

CSPC’s SYS 6043 Receives FDA Approval for Clinical Trials

Innovent's Limertinib Wins NMPA Approval for NSCLC Treatment
CompanyDrug

Innovent’s Limertinib Wins NMPA Approval for NSCLC Treatment

ConjuStar Completes $15 Million Pre-A+ Financing Round
Company

ConjuStar Completes $15 Million Pre-A+ Financing Round